Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002573254 | SCV003624847 | uncertain significance | Inborn genetic diseases | 2022-11-10 | criteria provided, single submitter | clinical testing | The c.287A>T (p.D96V) alteration is located in exon 2 (coding exon 2) of the THG1L gene. This alteration results from a A to T substitution at nucleotide position 287, causing the aspartic acid (D) at amino acid position 96 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV001579772 | SCV004227155 | uncertain significance | not provided | 2023-02-24 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001579772 | SCV001808464 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001579772 | SCV001974521 | uncertain significance | not provided | no assertion criteria provided | clinical testing |